CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase

Eur J Immunol. 1998 Oct;28(10):3003-16. doi: 10.1002/(SICI)1521-4141(199810)28:10<3003::AID-IMMU3003>3.0.CO;2-W.

Abstract

Occupancy of the B cell glycoprotein, CD72 results in syk-independent activation of phospholipase-C gamma and calcium mobilization. The cytoplasmic tail of CD72 does not contain an immunoreceptor tyrosine-based activation motif to directly transduce signals into the B lymphocyte. Hence, we investigated whether other coreceptors such as CD19 and its associated phosphatidylinositol 3-kinase (PI 3-K) were involved in CD72 signaling. Two specific inhibitors of PI 3-K inhibited CD72-stimulated B cell proliferation in a dose-dependent manner. Activation of B lymphocytes via CD72 resulted in recruitment and activation of PI 3-K, which was mediated by CD19. Accordingly, CD72 ligation induced CD19 tyrosine phosphorylation. Thus, lipid products generated as a result of PI 3-K activation may have an important function in CD72-mediated B lymphocyte activation. The kinetics of CD19 tyrosine phosphorylation induced by CD72 ligation were strikingly different from those seen following B cell antigen receptor (BCR) stimulation. A transient increase in the tyrosine phosphorylation of the complement receptors, CD21 and CD35 was observed in BCR- but not CD72-stimulated cells. Co-cross-linking of CD72 and CD19 failed to induce syk tyrosine phosphorylation suggesting that even under these conditions, CD72 signaling was independent of syk activation. A transient and stimulation-dependent physical association between CD19 and CD72 was observed in CD72-ligated cells. These observations suggest a mechanism by which CD72 can recruit CD19 and influence activation of CD19-associated PI 3-K, which appears to be critical for CD72-mediated B cell activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Antigens, CD / metabolism*
  • Antigens, CD19 / metabolism*
  • Antigens, Differentiation, B-Lymphocyte / metabolism*
  • B-Lymphocytes / cytology
  • B-Lymphocytes / metabolism*
  • Cell Division / drug effects
  • Chromones / pharmacology
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Enzyme Precursors / metabolism
  • Female
  • Immunoglobulin alpha-Chains / metabolism
  • Intracellular Signaling Peptides and Proteins
  • Lymphocyte Activation*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Morpholines / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein-Tyrosine Kinases / metabolism
  • Receptors, Complement 3b / metabolism
  • Receptors, Complement 3d / metabolism
  • Receptors, IgG / metabolism
  • Syk Kinase
  • Tyrosine / metabolism
  • Wortmannin

Substances

  • Androstadienes
  • Antigens, CD
  • Antigens, CD19
  • Antigens, Differentiation, B-Lymphocyte
  • CD72 protein, human
  • Chromones
  • Enzyme Inhibitors
  • Enzyme Precursors
  • Immunoglobulin alpha-Chains
  • Intracellular Signaling Peptides and Proteins
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Complement 3b
  • Receptors, Complement 3d
  • Receptors, IgG
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Tyrosine
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
  • Syk protein, mouse
  • Wortmannin